Kiro’s €13.8 Million Series A

Goodwin Procter advised Kiro on the deal. Kiro, a developer of a diagnosis platform designed to assist medical examinations, announced its €13.8 million Series A. This financing...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Xelya’s OBO

Chammas & Marcheteau advised Xelya and the sellers in the framework of the OBO. Goodwin and MB Avocats advised Parquest. The founders of Xelya, together with...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here